相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ultrasonographic Efficacy of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis From a Multicenter Rheumatoid Arthritis Ultrasound Prospective Cohort in Japan
Ayako Nishino et al.
ARTHRITIS CARE & RESEARCH (2018)
Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients-A longitudinal analysis
Carolin Wunderlich et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial
Jeremy Sokolove et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Jennifer Pieper et al.
BMC IMMUNOLOGY (2013)
Abatacept use in rheumatoid arthritis: Evidence review and recommendations
Emilio Martin Mola et al.
REUMATOLOGIA CLINICA (2013)
Treating rheumatoid arthritis to target: recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
A permutation test to compare receiver operating characteristic curves
ES Venkatraman
BIOMETRICS (2000)
分享论文
